<DOC>
	<DOCNO>NCT01344681</DOCNO>
	<brief_summary>This study chemotherapy occur neutropenic fever patient antibiotic refractory fever . The investigator evaluate efficacy safety micafungin sodium ( mycamine ® Injection ) 100mg dose compare itraconazole ( Sporanox ® Injection ) 200mg control study prospective , randomize , non-inferiority trial . Therefore , study plan review safety efficacy korean patient .</brief_summary>
	<brief_title>Micafungin Versus Intravenous Itraconazole Empirical Antifungal Therapy Febrile Neutropenic Patients With Hematological Diseases</brief_title>
	<detailed_description />
	<mesh_term>Neutropenia</mesh_term>
	<mesh_term>Fever</mesh_term>
	<mesh_term>Febrile Neutropenia</mesh_term>
	<mesh_term>Hematologic Diseases</mesh_term>
	<mesh_term>Itraconazole</mesh_term>
	<mesh_term>Micafungin</mesh_term>
	<mesh_term>Hydroxyitraconazole</mesh_term>
	<mesh_term>Antifungal Agents</mesh_term>
	<mesh_term>Miconazole</mesh_term>
	<mesh_term>Echinocandins</mesh_term>
	<criteria>The male female patient 18 year To participate clinical trial voluntary write consent requirement comply patient Chemotherapy variety hematologic malignancy patient undergo stem cell transplantation Fever ( temperature ≥ 38.4 ℃ ) show Neutropenia ( absolute neutrophil count &lt; 500/mm3 ) patient Combined antibiotic therapy 72 hour expiration term last three patient Of clinical trial breastfeed pregnant woman childbearing age intent Adapted specie ( candida genus , aspergillus genus ) Colitis cause fungi patient fungal infection HIVpositive patient serum This test within 30 day assignment patient participate clinical trial Within 72 hour registration patient treat systemic antifungal agent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>